Take part in the Phase 3 clinical study for people with walking problems at least 6 months after an ischemic stroke

Join the MILESTONE(TM) Stroke Study per the NSA.

Your choice. Ask your doctor why they haven't told you about this study before you ask them about it?

The actual study here with the drug being tested:

A Study to Evaluate the Efficacy and Safety of Two Dose Strengths of Dalfampridine Extended Release Tablets for Treatment of Stable Walking Deficits in Post-Ischemic Stroke (MILESTONE℠)

 The NSA news release:

Take part in the Phase 3 clinical study for people with walking problems at least 6 months after an ischemic stroke

Why is this study important?

Currently, there are no FDA approved medications available for improving the walking problems in these patients. Physical therapy and rehabilitation are the current mainstays of treatment to assist with walking problems following a stroke. Pharmaceutical companies use medical research studies such as the MILESTONE^SM Stroke Study to learn more about unapproved medications before they are made available to the public. By taking part in this study, you will be making a contribution to stroke therapy research.

What are the challenges related to this study?

The investigational medication has been approved as a treatment to improve walking problems associated with a different disease, however not in patients recovering from a stroke. This use is still investigational. The investigational medication is being tested in people who have had an ischemic stroke, because this condition has some nervous system changes that may be similar to what is seen in the disease for which this medication is approved. In an earlier study with about 80 participants who have had a stroke, there was some initial evidence of improvement in walking while taking the investigational medication twice a day for 2 weeks, when compared with a placebo.

TO PRE-QUALIFY FOR THIS STUDY, YOU MUST: be 18 years of age or older have had an ischemic stroke 6 months ago or longer have walking problems as a result of the ischemic stroke, such as walking more slowly or needing to use a cane or walker. YOU MUST NOT: have a history of seizures, except simple febrile seizures have moderate or severe renal impairment have had Botox within the past 2 months be pregnant, breastfeeding, or planning to become pregnant (if you are a woman able to have children).

All study-related visits, assessments, and study medication will be provided to participants at no cost. In addition, compensation for time and travel may be provided.

OR CALL

1-866-735-3667